Literature DB >> 33253778

TCDD attenuates EAE through induction of FasL on B cells and inhibition of IgG production.

Evangel Kummari1, Erin Rushing1, Ashleigh Nicaise1, Amye McDonald1, Barbara L F Kaplan2.   

Abstract

Previously we demonstrated that 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppressed experimental autoimmune encephalomyelitis (EAE), a model to study multiple sclerosis (MS), through induction of regulatory T cells (Tregs) and suppression of effector T cell function in the spleen. Since B cells and specifically regulatory B cells (Bregs) have been shown to be so critical in the pathology associated with EAE and MS, we wanted to determine whether TCDD could also induce Bregs. We specifically hypothesized that a Fas ligand (FasL)+ Breg population would be induced by TCDD in EAE thereby triggering apoptosis in Fas-expressing effector T cells as one mechanism to account for inhibition of T cell function by TCDD. TCDD (0.1-2.5 μg/kg/day administered orally for 12 days) modestly increased the percentage of FasL + B cells in the spleen and spinal cord in TCDD-treated EAE mice. However, we did not detect significant increases in percentages of FasL + B cells using TCDD in vitro in mouse splenocytes or human peripheral blood mononuclear cells (PBMCs). Part of the modest effect by TCDD was likely related to the localized expression of FasL; for instance, in the spleen, FasL was more highly expressed by IgMhiIgDlo marginal zone (MZ) B cells, but IgMloIgDhi follicular (FO) B cells were more responsive to TCDD. Consistent with our observation of modest upregulation of FasL, we also observed modest changes in mitochondrial membrane potential in T cells co-cultured with isolated total B cells or IgM-depleted (i.e., FO-enriched) B cells from TCDD-treated EAE mice. These data suggest that while small microenvironments of apoptosis might be occurring in T cells in response to TCDD-treated B cells, it is not a major mechanism by which T cell function is compromised by TCDD in EAE. TCDD did robustly suppress IgG production systemically and in spleen and spinal cord B cells at end stage disease. Thus, these studies show that TCDD's primary effect on B cells in EAE is compromised IgG production but not FasL + Breg induction.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AhR ligands; Autoimmunity

Mesh:

Substances:

Year:  2020        PMID: 33253778      PMCID: PMC7785643          DOI: 10.1016/j.tox.2020.152646

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  50 in total

1.  Comparison of sensitivity of Th1, Th2, and Th17 cells to Fas-mediated apoptosis.

Authors:  Yujiang Fang; Shiguang Yu; Jason S Ellis; Tumenjargal Sharav; Helen Braley-Mullen
Journal:  J Leukoc Biol       Date:  2010-06       Impact factor: 4.962

2.  Upregulation of CD19⁺CD24(hi)CD38(hi) regulatory B cells is associated with a reduced risk of acute lung injury in elderly pneumonia patients.

Authors:  Haihan Song; Jianjun Xi; Guang-Gang Li; Shumin Xu; Chunmei Wang; Tingting Cheng; Hongqiang Li; Ying Zhang; Xiandong Liu; Jianwen Bai
Journal:  Intern Emerg Med       Date:  2016-01-12       Impact factor: 3.397

3.  Morbidity in New Zealand pesticide producers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

Authors:  Andrea 't Mannetje; Amanda Eng; Chris Walls; Evan Dryson; Jeroen Douwes; Pier Bertazzi; Simon Ryder-Lewis; David Scott; Collin Brooks; Dave McLean; Soo Cheng; Neil Pearce
Journal:  Environ Int       Date:  2017-10-12       Impact factor: 9.621

4.  Soluble egg antigen-stimulated T helper lymphocyte apoptosis and evidence for cell death mediated by FasL(+) T and B cells during murine Schistosoma mansoni infection.

Authors:  S K Lundy; S P Lerman; D L Boros
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

5.  Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD)-induced immunotoxicity: increased resistance of thymocytes from Fas-deficient (lpr) and Fas ligand-defective (gld) mice to TCDD-induced toxicity.

Authors:  A B Kamath; I Camacho; P S Nagarkatti; M Nagarkatti
Journal:  Toxicol Appl Pharmacol       Date:  1999-10-15       Impact factor: 4.219

6.  Examination of immune parameters and host resistance mechanisms in B6C3F1 mice following adult exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  R V House; L D Lauer; M J Murray; P T Thomas; J P Ehrlich; G R Burleson; J H Dean
Journal:  J Toxicol Environ Health       Date:  1990-11

7.  Effects of chronic exposure to DDT and TCDD on disease activity in murine systemic lupus erythematosus.

Authors:  J Li; R W McMurray
Journal:  Lupus       Date:  2009-10       Impact factor: 2.911

8.  All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  Qiang Zhang; Douglas E Kline; Sudin Bhattacharya; Robert B Crawford; Rory B Conolly; Russell S Thomas; Melvin E Andersen; Norbert E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  2013-01-26       Impact factor: 4.219

9.  Aryl-hydrocarbon receptor-dependent pathway and toxic effects of TCDD in humans: a population-based study in Seveso, Italy.

Authors:  Andrea Baccarelli; Angela C Pesatori; Scott A Masten; Donald G Patterson; Larry L Needham; Paolo Mocarelli; Neil E Caporaso; Dario Consonni; Jean A Grassman; Pier Alberto Bertazzi; Maria Teresa Landi
Journal:  Toxicol Lett       Date:  2004-04-01       Impact factor: 4.372

Review 10.  Immunologic effects of dioxin: new results from Seveso and comparison with other studies.

Authors:  Andrea Baccarelli; Paolo Mocarelli; Donald G Patterson; Matteo Bonzini; Angela C Pesatori; Neil Caporaso; Maria Teresa Landi
Journal:  Environ Health Perspect       Date:  2002-12       Impact factor: 9.031

View more
  5 in total

1.  Isolation of Transcriptomic-Quality Total RNA from Mouse Spinal Cords.

Authors:  John V Stokes; Ashleigh J Nicaise; Christa M Frodella; Andrea S Varela-Stokes; Tom Thompson; Barbara L F Kaplan
Journal:  Curr Protoc       Date:  2022-01

2.  AhR Activation Leads to Attenuation of Murine Autoimmune Hepatitis: Single-Cell RNA-Seq Analysis Reveals Unique Immune Cell Phenotypes and Gene Expression Changes in the Liver.

Authors:  Alkeiver S Cannon; Bryan Latrell Holloman; Kiesha Wilson; Kathryn Miranda; Nicholas Dopkins; Prakash Nagarkatti; Mitzi Nagarkatti
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

Review 3.  Advances of Regulatory B Cells in Autoimmune Diseases.

Authors:  Qiugang Zhu; Ke Rui; Shengjun Wang; Jie Tian
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

4.  TCDD Inhibition of IgG1 Production in Experimental Autoimmune Encephalomyelitis (EAE) and In Vitro.

Authors:  Ashleigh J Nicaise; Amye McDonald; Erin Rushing Sears; Trell Sturgis; Barbara L F Kaplan
Journal:  Antibodies (Basel)       Date:  2022-01-09

5.  Consensus on the Key Characteristics of Immunotoxic Agents as a Basis for Hazard Identification.

Authors:  Dori R Germolec; Herve Lebrec; Stacey E Anderson; Gary R Burleson; Andres Cardenas; Emanuela Corsini; Sarah E Elmore; Barbara L F Kaplan; B Paige Lawrence; Geniece M Lehmann; Curtis C Maier; Cliona M McHale; L Peyton Myers; Marc Pallardy; Andrew A Rooney; Lauren Zeise; Luoping Zhang; Martyn T Smith
Journal:  Environ Health Perspect       Date:  2022-10-06       Impact factor: 11.035

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.